Lakefront Biotherapeutics · EURONEXT:LKFT
Tang Capital Management LLC reported a 7.50% stake in Lakefront Biotherapeutics (Schedule 13D)
Event Feb 7, 2025 · Filed Feb 14, 2025
Tang Capital Management LLC reported a 7.50% stake in Lakefront Biotherapeutics, 4,910,525 shares, with active intent on Feb 7, 2025. Filed Feb 14, 2025 (Schedule 13D).
- Stake
- 7.50%
- Shares
- 4,910,525
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 7.50% | 4,910,525 |
| KEVIN TANG | 7.50% | 4,910,525 |
| TANG CAPITAL PARTNERS, LP | 4.20% | 2,723,147 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 3.00% | 1,962,418 |
| TANG CAPITAL PARTNERS III, INC | 0.30% | 224,960 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
| CONCENTRA BIOSCIENCES, LLC | 0% | 0 |
Source
Related
- Lakefront Biotherapeutics
- Tang Capital Management LLC
- Lakefront Biotherapeutics shareholders
- Schedule 13G · Tang Capital Management LLC · Oct 29, 2025
- Schedule 13G · Madison Avenue Partners, LP · Jun 23, 2026
- Schedule 13D/A · EcoR1 Capital, LLC · Jul 28, 2025
- Schedule 13D/A · EcoR1 Capital, LLC · May 19, 2025
- Schedule 13D/A · Gilead Sciences, Inc. · Jan 10, 2025